Nanxiang Ouyang

机构：First Hospital of China Medical University, China Medical University · ORCID：0000-0001-9629-4557

发表论文 28 篇 · 总被引 497 次 · h-index 9

代表论文

• Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial (2023 · The Lancet · 被引 141)
• The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches (2023 · Basic Research in Cardiology · 被引 103)
• Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trial (2025 · Nature Medicine · 被引 45)
• Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials (2025 · The Lancet · 被引 38)
• Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension (2024 · JAMA Cardiology · 被引 33)
• Rationale and Design of a Cluster Randomized Trial of a Village Doctor-Led Intervention on Hypertension Control in China (2021 · American Journal of Hypertension · 被引 27)